GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Manuka Inc (OTCPK:MNKA) » Definitions » Common Stock

Manuka (Manuka) Common Stock : $1.12 Mil (As of Sep. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Manuka Common Stock?

Manuka's quarterly common stock increased from Sep. 2022 ($0.00 Mil) to Jun. 2023 ($1.12 Mil) but then stayed the same from Jun. 2023 ($1.12 Mil) to Sep. 2023 ($1.12 Mil).


Manuka Common Stock Historical Data

The historical data trend for Manuka's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Manuka Common Stock Chart

Manuka Annual Data
Trend
Common Stock

Manuka Quarterly Data
Jun22 Sep22 Jun23 Sep23
Common Stock - - 1.12 1.12

Manuka Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Manuka (Manuka) Business Description

Traded in Other Exchanges
N/A
Address
3 Eliezer Vardinon Street, Petach Tikva, ISR, 4959507
Manuka Inc is a beauty company that develops and distributes premium-quality skincare products, that are based on M?nuka honey and bee venom. Its skincare products are manufactured in Israel by its vendor, Chic with M?nuka honey ingredients. The company imports Manuka honey from its supplier in New Zealand, Waitemata Honey pursuant to the Supply Agreement. Currently, it operates only in Israel through the online platform. Its website and mobile applications currently offer six cosmetic skincare products: Face Serum with Manuka Honey and Bee Venom; Face Serum with enhanced Vitamin C; Day Cream; Night nourishing Cream; Eye Cream; and Face Cleanser Gel.
Executives
David Dana officer: Chief Financial Officer 3 ELIEZER VARDINON ST., PETACH TIKVA L3 4959507
Shimon Citron director, officer: Chief Executive Officer
Brian M Culley officer: Chief Executive Officer 6725 MESA RIDGE ROAD, SUITE 100, SAN DIEGO CA 92121
Peter N. Payne officer: Chief Executive Officer C/O NEW YORK GLOBAL INNOVATIONS INC., 18 E. 16TH STREET, SUITE 307, NEW YORK NY 10003
Dana Wolf officer: Chief Scientific Officer 18 EAST 16TH STREET, SUITE 307, NEW YORK NY 10003
Tonak Ltd. 10 percent owner 18 EAST 16TH STREET, SUITE 307, NEW YORK NY 10003
Israel Alfassi director 18 EAST 16TH STREET, SUITE 307, NEW YORK NY 10003
Chanan Morris officer: Chief Financial Officer 30 HAKTORET STREET, EFRAT L3 90435
Arias Roberto Alonso Jimenez director C/O NEW YORK GLOBAL INNOVATIONS INC., 18 EAST 16TH ST., SUITE 307, NEW YORK NY 10003
Tomer Assis officer: Chief Financial Officer C/O INKSURE TECHNOLOGIES INC., 18 EAST 16TH ST., SUITE 307, NEW YORK NY 10003
David W Sass director, officer: Secretary 260 MADISON AVE 18TH FLR, NEW YORK NY 10016
David Avner officer: CHIEF FINANCIAL OFFICER 1 HAMADA ST, REHOVOT L3 76703
Jonathan Bettsak director C/O INKSURE LTD 1 HAMADA ST., THE RABIN SCIENCE PARK, REHOVOT L3 76703
Tal Gilat officer: President and CEO C/O INKSURE, 1 HAMADA ST., REHOVOT L3 76703
Alon Raich director C/O ICTS INTERNATIONAL, N.V., BIESBOSCH 225, 1181 JC AMSTELVEEN P7 0000000000

Manuka (Manuka) Headlines

No Headlines